Scientists

ASSIA announces EQUIPE™: Industry's first Work-From-Home Residential Connectivity Management Platform for SMB & Enterprise Markets

Retrieved on: 
Thursday, September 10, 2020

REDWOOD CITY, California, Sept. 10,2020 /PRNewswire/ -- Adaptive Spectrum and Signal Alignment, Inc. (ASSIA), industry pioneer for AI-driven residential internet connectivity, announces the launch of EQUIPE, the first work from home connectivity management platform for the SMB & enterprise markets.

Key Points: 
  • REDWOOD CITY, California, Sept. 10,2020 /PRNewswire/ -- Adaptive Spectrum and Signal Alignment, Inc. (ASSIA), industry pioneer for AI-driven residential internet connectivity, announces the launch of EQUIPE, the first work from home connectivity management platform for the SMB & enterprise markets.
  • Additionally, there will be a product pre-launch presentation by ASSIA executives, sharing the benefits of EQUIPE.
  • EQUIPE provides SMB/enterprise IT admins with tools to remotely monitor and improve the internet connectivity for working from home.
  • SMB and enterprise companies don't have the same visibility or control over the quality of internet connectivity for their remote employees.

Rosalind Franklin University Brain Disease Conference Explores The Burden Of Neurological Diseases In The U.S.: New Initiatives For Diagnosing And Treating Brain Diseases

Retrieved on: 
Tuesday, September 8, 2020

The symposium, titled "Investing in Brain Disease Research," is being organized by Amiel Rosenkranz, PhD,director of RFU's Brain Science Institute.

Key Points: 
  • The symposium, titled "Investing in Brain Disease Research," is being organized by Amiel Rosenkranz, PhD,director of RFU's Brain Science Institute.
  • Venture capital groups including corporate venture capital groups that fund early-stage company research will also participate in the program.
  • Dr. Rosenkranz said it is a critical and opportune time to convene the multiple players in brain-disease research fields.
  • The university embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA.

2021 Vilcek Foundation Prizes in Biomedical Science Recognize Immigrant Leaders in STEM

Retrieved on: 
Tuesday, September 8, 2020

NEW YORK, Sept. 8, 2020 /PRNewswire/ --The Vilcek Foundation is pleased to announce the recipients of the 2021 Vilcek Foundation Prizes in Biomedical Science.

Key Points: 
  • NEW YORK, Sept. 8, 2020 /PRNewswire/ --The Vilcek Foundation is pleased to announce the recipients of the 2021 Vilcek Foundation Prizes in Biomedical Science.
  • Awarded annually, these awards comprising the Vilcek Prize in Biomedical Science and three Vilcek Prizes for Creative Promise in Biomedical Science honor the contributions of immigrants to scientific research, discovery, and innovation in the United States.
  • The Vilcek Prize in Biomedical Science recognizes an immigrant scientist for outstanding career contributions to biomedical science and global scientific research.
  • The Vilcek Foundation has also announced the recipients of the 2021 Vilcek Prize and Vilcek Prizes for Creative Promise in Filmmaking, and the 2021 Vilcek Prize for Excellence in Public Service.

Vilcek Foundation Awards Prizes Totaling $600,000

Retrieved on: 
Tuesday, September 8, 2020

NEW YORK, Sept. 8, 2020 /PRNewswire/ -- The Vilcek Foundation has announced the recipients of the 2021 Vilcek Foundation Prizes, totaling $600,000.

Key Points: 
  • NEW YORK, Sept. 8, 2020 /PRNewswire/ -- The Vilcek Foundation has announced the recipients of the 2021 Vilcek Foundation Prizes, totaling $600,000.
  • The 2021 prizes include the Vilcek Prize in Biomedical Science, the Vilcek Prize in Filmmaking, the Vilcek Prize for Excellence in Public Service, and a total of six Creative Promise Prizesthree each in biomedical science and in filmmaking.
  • Inaugurated in 2019, the Vilcek Prize for Excellence is the newest honor bestowed by the Vilcek Foundation as part of the Vilcek Foundation Prizes.
  • The Vilcek Foundation is a private operating foundation, a federally tax-exempt nonprofit organization under IRS Section 501(c)(3).

Columbus Citizens Foundation Launches Dr. Anthony S. Fauci Scholarship - Created For Graduate Students in Medical and Public Health Fields

Retrieved on: 
Wednesday, August 26, 2020

Dr. Fauci will also be honored formally with the Columbus Citizens Foundation's Humanitarian Award in October 2021, when an in-person Gala event can be held.

Key Points: 
  • Dr. Fauci will also be honored formally with the Columbus Citizens Foundation's Humanitarian Award in October 2021, when an in-person Gala event can be held.
  • Through this perpetual scholarship program, our Foundation will continually pay tribute to this great Italian-American by providing needed assistance to the next generations of public health and medical trailblazers emerging from our community."
  • We are proud to be the first lead sponsor in what will be a very special scholarship for Columbus Citizens Foundation."
  • Columbus Citizens Foundation is a non-profit organization in New York City committed to fostering an appreciation of Italian-American heritage and achievement.

Columbus Citizens Foundation Launches Dr. Anthony S. Fauci Scholarship - Created For Graduate Students In Medical And Public Health Fields

Retrieved on: 
Wednesday, August 26, 2020

Dr. Fauci will also be honored formally with the Columbus Citizens Foundation's Humanitarian Award in October 2021, when an in-person Gala event can be held.

Key Points: 
  • Dr. Fauci will also be honored formally with the Columbus Citizens Foundation's Humanitarian Award in October 2021, when an in-person Gala event can be held.
  • CCF President, Marian Pardo, said of the announcement: "During his entire career Dr. Fauci has pursued the public good through sound science, rigorouslyappliedand clearly explained.
  • Through this perpetual scholarship program, our Foundation will continually pay tribute to this great Italian-American byproviding needed assistance to the next generations of public health and medical trailblazers emerging from our community."
  • We are proud to be the first lead sponsor in what will be a very special scholarship for Columbus Citizens Foundation."

Kronos Bio Announces $155 Million Private Financing

Retrieved on: 
Monday, August 24, 2020

Kronos Bio, Inc., a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription, today announced a private financing of approximately $155 million of convertible notes, with $148 million in funding received to date and the remaining $7 million to be funded by mid-September pursuant to binding commitments.

Key Points: 
  • Kronos Bio, Inc., a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription, today announced a private financing of approximately $155 million of convertible notes, with $148 million in funding received to date and the remaining $7 million to be funded by mid-September pursuant to binding commitments.
  • We appreciate the strong support from this group of investors and believe this capital will help propel Kronos through our upcoming period of clinical development, said Norbert Bischofberger, Ph.D., President and Chief Executive Officer of Kronos.
  • Jefferies LLC acted as the sole placement agent for the financing.
  • Kronos Bio is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Dr. Anthony Fauci Joins Healthline Live Town Hall on Coronavirus

Retrieved on: 
Monday, August 17, 2020

Healthline Media will hold a free online live town hall meeting featuring Director of the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Anthony S. Fauci, M.D.

Key Points: 
  • Healthline Media will hold a free online live town hall meeting featuring Director of the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Anthony S. Fauci, M.D.
  • The Healthline Live Town Hall will take place on Tuesday, August 18, from 11:45 a.m.-12:45 p.m. EDT.
  • The event will be free to watch on Healthlines home page , Facebook Live and YouTube without registration.
  • Dr. Fauci and our other Healthline Live Town Hall panelists have dedicated their careers to speaking the truth and seeking cures for diseases that affect us all.

Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal

Retrieved on: 
Thursday, August 13, 2020

WASHINGTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.

Key Points: 
  • WASHINGTON, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.
  • We are pleased to present the Gold Medal to Gordon, said Amy Finan, Sabins chief executive officer.
  • Next, Professor Dougan assembled a world class program for teaching and research at the Wellcome Sanger Institute in Cambridge.
  • View the video highlighting the 2020 Albert B. Sabin Gold Medal and Sabin Rising Star Award, including remarks by Professor Dougan and Dr. Gallagher, as well as their introducers, Dr. Myron M. Levine, University of Maryland School of Medicine, and Dr. Anthony Scott, London School of Hygiene & Tropical Medicine.

Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal

Retrieved on: 
Thursday, August 13, 2020

Washington, D.C., Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.

Key Points: 
  • Washington, D.C., Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge.
  • We are pleased to present the Gold Medal to Gordon, said Amy Finan, Sabins chief executive officer.
  • Next, Professor Dougan assembled a world class program for teaching and research at the Wellcome Sanger Institute in Cambridge.
  • View the video highlighting the 2020 Albert B. Sabin Gold Medal and Sabin Rising Star Award, including remarks by Professor Dougan and Dr. Gallagher, as well as their introducers, Dr. Myron M. Levine, University of Maryland School of Medicine, and Dr. Anthony Scott, London School of Hygiene & Tropical Medicine.